PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
This Quarter Return
+1.75%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
10 Year Return
AUM
$1.47B
AUM Growth
+$230M
Cap. Flow
+$271M
Cap. Flow %
18.5%
Top 10 Hldgs %
60.98%
Holding
36
New
6
Increased
19
Reduced
3
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ROIV icon
26
Roivant Sciences
ROIV
$8.67B
$12.6M 0.86%
+1,081,767
New +$12.6M
KURA icon
27
Kura Oncology
KURA
$719M
$11.1M 0.75%
1,212,828
+207,920
+21% +$1.9M
CMPS
28
Compass Pathways
CMPS
$457M
$10.1M 0.68%
+1,358,709
New +$10.1M
COGT icon
29
Cogent Biosciences
COGT
$1.83B
$2.2M 0.15%
+225,605
New +$2.2M
ETNB icon
30
89bio
ETNB
$1.36B
0
MDGL icon
31
Madrigal Pharmaceuticals
MDGL
$9.63B
-85,000
Closed -$19.6M
MLTX icon
32
MoonLake Immunotherapeutics
MLTX
$3.72B
-369,615
Closed -$18.9M
VIR icon
33
Vir Biotechnology
VIR
$783M
-1,014,239
Closed -$24.9M
ONC
34
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.4B
-216,093
Closed -$38.5M
KRTX
35
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-283,605
Closed -$61.5M
THRX
36
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-1,950,327
Closed -$18.2M